Skip to main content
Clinical Trials/NCT01065168
NCT01065168UnknownNot Applicable

Serial Measurement of Serum Antimullerian Hormone in Women Undergoing Laparoscopic Cystectomy of Endometrioma

Mahidol University0 sites43 target enrollmentStarted: January 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
43
Primary Endpoint
Ovarian reserve before and after ovarian endometrioma cystectomy.

Study Overview

Brief Summary

The purpose of this trial is to study ovarian reserve after laparoscopic endometrioma cystectomy by measuring antimullerian hormone. The measurements were measured before the surgery and one week and three months after the surgery.

Detailed Description

Antimullerian hormone will be obtained in patients with ovarian endometrioma before laparoscopic cystectomy is done. The measurements were compared with antimullerian hormone after one week and three months after the surgery. Forty three patients will be included in this study.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
20 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 20-40 years
  • ovarian endometrioma > or = 3 cms
  • laparoscopic cystectomy treatment

Exclusion Criteria

  • previous ovarian surgery
  • other ovarian pathology
  • previous drugs or hormonal treatment for endometrioma

Outcomes

Primary Outcomes

Ovarian reserve before and after ovarian endometrioma cystectomy.

Time Frame: one week and three months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Similar Trials